Background: Bone metastases are one of the most frequent complications of advanced cancers and one of the therapies used for the palliative treatment of pain associated with them is radiopharmaceutical therapy. Like any other drug, radiopharmaceuticals can cause adverse reactions (AR). Therefore, a global and up-to-date view of AR related to radiopharmaceuticals is essential, to allow the detection, understandi...